Lv1
40 积分 2025-08-04 加入
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
3个月前
已完结
UGT1A1 and Sacituzumab Govitecan Toxicity: A Systematic Review and Meta‐Analysis
4个月前
已完结
Glucose restriction shapes pre-metastatic innate immune landscapes in the lung through exosomal TRAIL
5个月前
已完结
Novel Insights Into Small Open Reading Frame-Encoded Micropeptides in Glioblastoma
5个月前
已完结
A novel oncolytic poxvirus carrying CD47 nanomabs in the treatment of pancreatic cancer by reshaping the immune microenvironment
6个月前
已完结
Predictive value of NLR and PLR for immune-related adverse events: a systematic review and meta-analysis
6个月前
已完结
Tumor–Immune Cell Interactions in Cancer Progression
7个月前
已完结
USP28 promotes PARP inhibitor resistance by enhancing SOX9-mediated DNA damage repair in ovarian cancer
8个月前
已完结
Targeting 5-HT to Alleviate Dose-Limiting Neurotoxicity in Nab-Paclitaxel-Based Chemotherapy
8个月前
已完结
皖公网安备34019202002308
